Advisor Group’s Anika Therapeutics ANIK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q4 | $27K | Sell |
522
-450
| -46% | -$23.3K | ﹤0.01% | 3781 |
|
|
2019
Q3 | $53K | Buy |
972
+352
| +57% | +$19.2K | ﹤0.01% | 3347 |
|
|
2019
Q2 | $25K | Buy |
620
+38
| +7% | +$1.53K | ﹤0.01% | 3815 |
|
|
2019
Q1 | $17K | Buy |
582
+49
| +9% | +$1.43K | ﹤0.01% | 4045 |
|
|
2018
Q4 | $18K | Sell |
533
-158
| -23% | -$5.34K | ﹤0.01% | 3853 |
|
|
2018
Q3 | $29K | Buy |
691
+38
| +6% | +$1.6K | ﹤0.01% | 3641 |
|
|
2018
Q2 | $21K | Sell |
653
-45
| -6% | -$1.45K | ﹤0.01% | 3672 |
|
|
2018
Q1 | $35K | Sell |
698
-277
| -28% | -$13.9K | ﹤0.01% | 3330 |
|
|
2017
Q4 | $52K | Sell |
975
-659
| -40% | -$35.1K | ﹤0.01% | 3050 |
|
|
2017
Q3 | $95K | Buy |
1,634
+137
| +9% | +$7.97K | ﹤0.01% | 2451 |
|
|
2017
Q2 | $74K | Sell |
1,497
-5
| -0.3% | -$247 | ﹤0.01% | 2546 |
|
|
2017
Q1 | $65K | Buy |
1,502
+1,170
| +352% | +$50.6K | ﹤0.01% | 2497 |
|
|
2016
Q4 | $16K | Sell |
332
-61
| -16% | -$2.94K | ﹤0.01% | 3344 |
|
|
2016
Q3 | $19K | Sell |
393
-76
| -16% | -$3.67K | ﹤0.01% | 3172 |
|
|
2016
Q2 | $24K | Buy |
+469
| New | +$24K | ﹤0.01% | 2941 |
|